
- Pharmaceutical Commerce - May/June 2010
After the merger: Survey identifies keys to successful integration
Corporate culture rated as an important risk-assessment factor in Best Practices survey
Can’t we all just get along? That’s what employees caught in the middle of last year’s biopharma mega-mergers might be asking themselves right now. The mergers were announced more than a year ago, but the critical post-integration period for the acquiring and acquired companies is happening now, points out Best Practices LLC (Chapel Hill, NC) in a report called “M&A Integration Excellence: What Biopharma Companies Need to Know Now.”
For the report, Best Practices interviewed personnel at 26 biopharma companies, including Pfizer, which announced its merger with Wyeth last spring. Interviewees ranged from CFOs and CTOs to new business integration specialists and marketing managers.
One of the main takeaways from the report: “Culture clashes can slow integrations and depress the value of acquired assets.”
To keep culture clashes in check, industry experts recommend employing an ongoing cultural integration process—one that starts early and is revisited even three years after the merger. Industry experts interviewed also recommend using staff rotations as a useful cultural integration and “cross-pollination” tool. “Companies that conduct frequent M&A activities look for opportunities to rotate senior staff—both from the acquiring and acquired companies—into key roles in the new assets and in the larger company,” the report explains. “Two-way rotations send a strong signal about the merging of cultures and underscore that talented people will always have an important role.”
Articles in this issue
over 15 years ago
Smoothing the Path to Drug Safetyover 15 years ago
Pharma, FDA Wrestle with Social Media Toolsover 15 years ago
Defending Fair Market Value (FMV) Assessmentsover 15 years ago
The Time Is Right to Reform Your Approach to Managed Careover 15 years ago
Deloitte 2010 Survey of Health Care Consumersover 15 years ago
Surprise! Employment Is on the Rise--in Contract Salesover 15 years ago
The Drive to Develop New Commercial Modelsover 15 years ago
Medical-Claims Database Analysis of Off-Label PrescribingNewsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.